# NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx

> **NCT01946867** · NA · UNKNOWN · sponsor: **Nanobiotix** · enrollment: 75 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DEVICE:** NBTXR3 activated by IMRT

## Key facts

- **NCT ID:** NCT01946867
- **Lead sponsor:** Nanobiotix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01-03
- **Primary completion:** 2023-02
- **Final completion:** 2023-02
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01946867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01946867, "NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01946867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*